Cited by 688Skin and Cellular Biology ResearchHereditary Neurological DisordersMultiple Sclerosis Research Studies

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

Open access

Petzold, Axel·2005·Journal of the Neurological Sciences

DOI 10.1016/j.jns.2005.03.015

Open this paper in CoChat — free account Open PDF

Abstract

This review on the role of neurofilaments as surrogate markers for axonal degeneration in neurological diseases provides a brief background to protein synthesis, assembly, function and degeneration. Methodological techniques for quantification are described and a protein nomenclature is proposed. The relevance for recognising anti-neurofilament autoantibodies is noted. Pathological implications are discussed in view of immunocytochemical, cell-culture and genetic findings. With reference to the present symposium on multiple sclerosis, the current literature on body fluid levels of neurofilaments in demyelinating disease is summarised.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2005.03.015

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
The cell: a molecular approach
(1997) · Choice Reviews Online · doi:10.5860/choice.35-0264 · Cited by 1,465
Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
A Structural Scaffolding of Intermediate Filaments in Health and Disease
Fuchs, E. V., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,013
The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons.
Hoffman, P. N., & Lasek, R. J. (1975) · The Journal of Cell Biology · doi:10.1083/jcb.66.2.351 · Cited by 941
Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
de Waegh, S. M., Lee, V. M. ‐., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 743
Neurofilament gene expression: a major determinant of axonal caliber.
Hoffman, P. N., Cleveland, D. W., Griffin, J. W., Landes, P. W., Cowan, N. J., & Price, D. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3472 · Cited by 719
A Mechanistic Analysis of Nondisruptive Axonal Injury: A Review
Maxwell, W. L., Povlishock, J. T., & Graham, D. I. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.419 · Cited by 564
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
Xu, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90157-l · Cited by 543
Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia
Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 539

Show all 135 references

Research works printed but not linked: 2

Bö L, Grey matter pathology in early MS. In: Miller, DH, Filipi M, A.J. Thompson, editors. MAGNIMS Clinically Isolated Syndrome Workshop, The National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, 22.–23. Jan. MS NMR Research, Unit, Department of Neuroinflammation; 2004.
Julien, 1999, Neurofilament functions in health and disease, Curr Opin Neurobiol, 9, 554, 10.1016/S0959-4388(99)00004-5 · DOI

Sorted by citations

Items 501–600 of 686

Serum Levels of Neurofilament-H are Elevated in Patients Suffering From Severe Burns
Gatson, J. W., Liu, M.-M., Rivera-Chávez, F. A., Minei, J., & Wolf, S. (2015) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000176 · Cited by 7
Traumatic Brain Injury
Morganti-Kossmann, C., Raghupathi, R., & Maas, A. I. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139030564.002 · Cited by 6
Comparative Study of CSF Neurofilaments in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis and Other Neurological Disorders
Alberti, C., Gonzalez, J., Maldonado, H., Medina, F., Barriga, A., Garcı́a, L., Kettlun, A. M., Collados, L., Puente, J., Cartier, L., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0262 · Cited by 6
Neurofilament localization and phosphorylation in the developing inner ear of the rat
Tonnaer, E. L. G. M., Peters, T. A., & Curfs, J. H. A. J. (2010) · Hearing Research · doi:10.1016/j.heares.2010.03.090 · Cited by 6
Neurofilament heavy chain and chitinase 3-like 1 as markers for monitoring therapeutic response in multiple sclerosis
Kušnierová, P., Revendová, K. Ž., Karasova, K., Zeman, D., Bunganic, R., Hradílek, P., Volný, O., Ganesh, A., Kovacova, I., & Stejskal, D. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105915 · Cited by 6
Rapid Point-of-Care-Tests for Stroke Monitoring
Tok, A. I. Y., & Marks, R. S. (2019) · Materials research foundations · doi:10.21741/9781644900376-8 · Cited by 6
Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer’s Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study
Shim, Y. (2023) · Current Alzheimer Research · doi:10.2174/0115672050284054240119101834 · Cited by 5
Differential expression of cytoskeletal genes in the cochlear nucleus
Friedland, D. R., Popper, P., Eernisse, R., Ringger, B., & Cioffi, J. A. (2006) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20303 · Cited by 5
NMDA Receptor Antagonism for Neuroprotection in a Canine Model of Hypothermic Circulatory Arrest
Giuliano, K. A., Etchill, E. W., Zhou, X. J., Lui, C., Suarez‐Pierre, A., Sharma, R. B., Wilson, M. A., Blue, M. E., Troncoso, J. C., Kannan, S., et al. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.11.075 · Cited by 5
Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis
Hermesdorf, M., Wulms, N., Maceski, A. M., Leppert, D., Benkert, P., Wiendl, H., Kühle, J., & Berger, K. (2023) · GeroScience · doi:10.1007/s11357-023-00846-x · Cited by 5
Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON
Hudson, G., Yu‐Wai‐Man, P., Griffiths, P. G., Horváth, R., Carelli, V., Zeviani, M., & Chinnery, P. F. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.03.004 · Cited by 5
Plasma neurofilament light mediates the effects of Apolipoprotein E on brain atrophy and cognitive decline in the comorbid Alzheimer's disease and cerebral small vessel disease
Zhang, C., Li, B., Ng, K. P., Tai, Y., Tai, Y., Song, X., Kong, M., & Ba, M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100054 · Cited by 4
Axonal degeneration in hemorrhagic stroke: A systematic review
Pasokh, A., Hadziavdic, L., Farr, T. D., & Zille, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107946 · Cited by 4
Non-Invasive Brain Stimulation for Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives
Toffola, J. D., Ricci, E., Quagliotto, M., Manganotti, P., & Benussi, A. (2025) · Medicina · doi:10.3390/medicina61091685 · Cited by 5
Bidirectional relationship between mitochondrial dysfunction and dysregulated lipid metabolism in Multiple Sclerosis: potential mechanisms and therapeutic implications
Xie, T., Fok, H. T., Quan, Z., Ku, C.-Y., Akefe, I. O., & Schweitzer, D. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107159 · Cited by 5
Electrochemical Strategies to Evaluate the Glycosylation Status of Biomolecules for Disease Diagnosis
Hormigos, R. M., Monago‐Maraña, O., & Crevillén, A. G. (2026) · Chemosensors · doi:10.3390/chemosensors14020038 · Cited by 4
Remodeling of the neuromuscular junction in myasthenia gravis increases serum neurofilament heavy chain levels
Wong, S. H., & Petzold, A. (2023) · Muscle & Nerve · doi:10.1002/mus.27838 · Cited by 4
Self-citation
J-shaped relationship of serum neurofilament light chain with urinary albumin excretion in US adults: NHANES 2013–2014
Liu, Y., Yang, Q., Zhang, Y., & Lin, J. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2391955 · Cited by 4
Association between serum neurofilament light chain levels and grip strength among US adults: a cross-sectional study using National Health and Nutrition Examination Survey data from 2013 to 2014
Dilixiati, D., Kadier, K., Qiao, B., Zhang, W., Nuerdebieke, D., Zebibula, A., Yang, Y., & Rexiati, M. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-084766 · Cited by 5
Serum Neurofilament Light as a Neuropsychiatric Disorder Screening Test in Psychiatric Emergency Settings
Zarglayoun, H., Jones, S. L., Light, V., Rousseau, K., Teunissen, C. E., & Ducharme, S. (2025) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20240228 · Cited by 4
Emerging themes from the literature on circulating biomarkers of traumatic brain injury
Paziana, K., & Korley, F. K. (2015) · Future Neurology · doi:10.2217/fnl.15.13 · Cited by 4
Avidity of antineurocytoskeletal antibodies in Alzheimer's disease patients
Nosková, L., Fialová, L., Bartoš, A., & Zima, T. (2017) · Biomedical Papers · doi:10.5507/bp.2017.017 · Cited by 4
Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview
Manzine, P. R., Vatanabe, I. P., Grigoli, M. M., Pedroso, R. V., Monteiro, M. P. A. O., de Oliveira, D. D. S. M. S., Nascimento, C. M. C., Peron, R., Orlandi, F. D. S., & Cominetti, M. R. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220408124809 · Cited by 4
Preliminary study of neurofilament light chain as a biomarker for hypoxia-induced neuronal injury in dogs
Yun, T., Chae, Y., Koo, Y., Lee, D., Kim, H., Yang, M., & Kang, B. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1284306 · Cited by 4
Changes in plasma concentrations of novel vascular and inflammatory biomarkers in obstructive sleep apnea patients pre- and post-stroke
Das, P., Wang, Y., Angom, R. S., Dredla, B. K., Wang, E., Jansen‐West, K. R., Badi, M. K., Ross, O. A., Meschia, J. F., & Mukhopadhyay, D. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.05.034 · Cited by 4
Multimodal Longitudinal Optical Imaging Reveals Optic Neuritis Preceding Retinal Pathology in Experimental Autoimmune Encephalomyelitis
Raspe, R., Günther, R., Uecker, R., Rakhymzhan, A. A., Paul, F., Radbruch, H., Niesner, R. A., & Hauser, A. E. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200338 · Cited by 4
Neurofilament heavy chain in secondary progressive multiple sclerosis
Angelis, F. D., Ammoscato, F., Parker, R. A., Plantone, D., Doshi, A., John, N. A., Williams, T. E., Stutters, J., MacManus, D. G., Schmierer, K., et al. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585241311212 · Cited by 4
Inflammation and White Matter Injury in Animal Models of Ischemic Stroke
Schlichter, L. C., Hutchings, S., & Lively, S. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9123-1_19 · Cited by 4
Biofluid Markers of Equine Neurological Disorders Reviewed From Human Perspectives
Mayaki, A. M., Razak, I. S. A., Adzahan, N. M., Mazlina, M., & Abdullah, R. (2019) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2019.102907 · Cited by 4
Lessons learned from proteome analysis of perinatal neurovascular pathologies
Menéndez-Valladares, P., Idígora, N. S., Fuerte‐Hortigón, A., Alonso-Pérez, I., Duque-Sánchez, C., Domínguez-Mayoral, A., Ybot‐González, P., & Montaner, J. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1807335 · Cited by 4
Type of serum collection tube does not impact neurofilament light chain levels
Sotirchos, E. S., Fitzgerald, K. C., Smith, M. D., Vasileiou, E. S., Resto, Y., Lord, H., Mowry, E. M., & Calabresi, P. A. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103676 · Cited by 4
Effect of carotid endarterectomy on brain damage markers
Iłżecki, M., Iłżecka, J., Przywara, S., Terlecki, P., Grabarska, A., Stepulak, A., & Zubilewicz, T. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12607 · Cited by 4
Neurodegeneration and Multiple Sclerosis
Petzold, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_18 · Cited by 4
Self-citation
Evaluation of serum neurofilament light chains levels for diagnosis, treatment monitoring and prognosis in multiple sclerosis
Alifirova, V. M., Kamenskikh, E. M., & Koroleva, E. S. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119107 · Cited by 5
Expression of high‐molecular‐mass neurofilament protein in horse (Equus caballus) spinal ganglion neurons
Russo, D., Castellani, G., & Chiocchetti, R. (2011) · Microscopy Research and Technique · doi:10.1002/jemt.21102 · Cited by 4
Biomarkers of Disease Progression
Petzold, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_6 · Cited by 4
Self-citation
The diagnostic significance of neurofilament heavy chains in cerebrospinal fluid in amyotrophic lateral sclerosis
Vladykina, A. V., Назаров, В. Д., Сергеевич, К. В., Koroleva, E. I., Fedorova, P. A., Moshnikova, A. N., Маzing, A. V., Lapin, S. V., Emanuel, V. L., Rudenko, D. I., et al. (2021) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2021.1.5 · Cited by 4
Potential Pathological Biomarkers in Multiple SclerosisPreprint
Mathur, D., Rout, S., Mishra, B., Rodas, G., Vallamkondu, J., Kandimalla, R., & Casanova, B. (2020) · Preprints.org · doi:10.20944/preprints202009.0293.v1 · Cited by 1
Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions
Russotto, A., Longobardi, A., Ciullini, A., Cazzaniga, F. A., Bacınoğlu, M. B., Borroni, B., Ghidoni, R., Moda, F., & Saraceno, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07471-6 · Cited by 5
Serum spectrin breakdown product and neurofilament heavy in predicting outcome after cardiac arrest: A diagnostic accuracy study
Kim, K. W., Oh, J. S., Kim, H. J., Song, H., Oh, S. H., Youn, C. S., Choi, K. H., & Park, K. N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22582 · Cited by 3
MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients
Musarò, A., Dobrowolny, G., Cambieri, C., Libonati, L., Moret, F., Casola, I., Laurenzi, G., Garibaldi, M., Inghilleri, M., & Ceccanti, M. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08773-6 · Cited by 3
Cerebrospinal fluid biomarkers of efficacy in patients affected by spinal muscular atrophy type 1 treated with nusinersen
Sframeli, M., Polito, F., Vita, G. L., Macaione, V., Gitto, E., Vita, G., Aguennouz, M., & Messina, S. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02784-1 · Cited by 3
Accuracy of blood-based neurofilament light to different genetic frontotemporal dementia from primary psychiatric disorders
Liu, E., Jones, S. L., Light, V., Teunissen, C. E., Bouzigues, A., Russell, L. L., Foster, P. H., Ferry‐Bolder, E., Swieten, J. C. V., Jiskoot, L. C., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352103 · Cited by 4
Neurofilaments light chain/Neurofilaments heavy chain
Yokobori, S., Nakae, R., & Yokota, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816346-7.00013-0 · Cited by 3
Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
Pan, C., Zhao, Y., Xie, H., Zhou, Y., Duan, R., Li, Y., Jia, Y., & Peng, T. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s322789 · Cited by 3
Vascular diseases and bleedings
Hegen, H., Auer, M., & Deisenhammer, F. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00013-7 · Cited by 3
A conscious rethink: Why is brain tissue commonly preserved in the archaeological record? Commentary on: Petrone P, Pucci P, Niola M, et al. Heat-induced brain vitrification from the Vesuvius eruption in C.E. 79. N Engl J Med 2020;382:383-4. DOI: 10.1056/NEJMc1909867
Morton-Hayward, A. L., Thompson, T. J. U., THOMAS‐OATES, J. E., Buckley, S., Petzold, A., Ramsøe, A. D., O’Connor, S., & Collins, M. J. (2020) · STAR Science & Technology of Archaeological Research · doi:10.1080/20548923.2020.1815398 · Cited by 3
Self-citation
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Viader, F. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.01.002 · Cited by 3
Biomarkers of Traumatic Brain Injury in the Geriatric Population
Rice, D., Wang, K., & Robicsek, S. A. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-012-0022-5 · Cited by 3
Biomarkers in Spinal Cord Injury
Yokobori, S., Hosein, K., & Wang, M. Y. (2014) · CRC Press eBooks · doi:10.1201/b17644-18 · Cited by 3
Elevated ALS Biomarker Levels in CSF of a FTD Patient at the Presymptomatic Stage of ALS
Cognat, E., Schaepdryver, M. D., Hugon, J., Poesen, K., & Paquet, C. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000222 · Cited by 3
Transiently structured head domains control intermediate filament assemblyPreprint
Zhou, X., Lin, Y., Liszczak, G., Sysoev, V. O., Sutherland, L. B., Mori, E., Murray, D. T., Kato, M., Tycko, R., & McKnight, S. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.27.012112 · Cited by 3
Reply
Gunnarsson, M., Malmeström, C., Rosengren, L., Lycke, J., & Svenningsson, A. (2011) · Annals of Neurology · doi:10.1002/ana.22450 · Cited by 3
Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder
Mei-juan, Y., Zhang, X., Zhang, D., Zhang, Y., Wang, J., Zhang, Y., Gu, C., Zhang, X., & Wei, L. (2025) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2024.0053 · Cited by 2
The relationship between mixed exposure to blood metal and serum neurofilament light chain levels in the general U.S. population: an unsupervised clustering approach
Nie, J., Lin, W. Y., Lai, Z., Lin, C., Li, H., Zhang, J., Xie, S., Ben, X., & Jing, C. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1516879 · Cited by 2
Next-generation approaches in autoimmune encephalitis diagnosis: A multi-omics perspective
Zhao, M., Li, J., Jin, L., & Luo, Z. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578740 · Cited by 2
Neurofilament light chain concentration mediates the association between regional cortical thickness and Parkinson’s disease with excessive daytime sleepiness
Chen, J., Jiang, G., Zhu, Y., Liang, C., Liu, C., Chen, J., Yang, B., & Yang, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1645290 · Cited by 2
Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4
Kessler, C., Wilke, C., Hengel, H., Rattay, T. W., Maceski, A. M., Kühle, J., Schöls, L. J., & Schüle, R. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2557936 · Cited by 2
Blast Overpressure-Induced Neuroinflammation and Axonal Injury in the Spinal Cord of Ferrets
Phuyal, G., Pundkar, C. Y., Govindarajulu, M., Thanapaul, R. J. R. S., Al-Lami, A., Menon, A., Long, J. B., & Arun, P. (2025) · Brain Sciences · doi:10.3390/brainsci15101050 · Cited by 2
Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer’s Disease
Gasca-Martínez, Y., Ontiveros‐Torres, M. Á., López-Gallegos, I., & Jarero-Basulto, J. J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010014 · Cited by 2
Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis
Taluntienė, V., Giedraitienė, N., Kizlaitienė, R., Vaišvilas, M., & Kaubrys, G. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1743472 · Cited by 2
Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS
López‐Blanch, R., Oriol‐Caballo, M., Estrela, J. M., & Obrador, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106727 · Cited by 3
Effect of stab injury in the rat cerebral cortex on temporal pattern of expression of neuronal cytoskeletal proteins: An immunohistochemical study
Lavrnja, I. C., Savić, D. Z., Parabucki, A., Đačić, S., Laketa, D., Peković, S., & Stojiljković, M. (2015) · Acta Histochemica · doi:10.1016/j.acthis.2014.12.004 · Cited by 2
The Utility of Biomarkers for Huntington’s Disease
Thomas, E. A. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_1 · Cited by 2
Predictive Clinical-Biological Markers Over the First 3 Years of Nusinersen Treatment in SMA Type 1 Patients
Badina, M., Mirea, A., Sporea, C., & Bejan, G. C. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.754 · Cited by 2
Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H
Badina, M., Bejan, G. C., Sporea, C., & Mirea, A. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.755 · Cited by 2
Proteolysis‐Based Biomarker Repertoire of the Neurofilament Proteome
Petzold, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70023 · Cited by 2
Self-citation
Biomarkers on anti-N-methyl-D-aspartate receptor encephalitis
He, M., & Wang, H. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.03.001 · Cited by 2
Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross‐Sectional Analysis From NHANES 2013–2014
Wei, J., Liu, Y., & Li, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70775 · Cited by 2
Central nervous system toxicity biomarkers
Costa, L. G., & Pellacani, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00009-9 · Cited by 2
Long-Term Astroglial Reaction and Neuronal Plasticity in the Subcortical Visual Pathways After a Complete Ablation of Telencephalon in Pigeons (Columba livia)
Cerutti, S. M., Gomide, V. C., Ferrari, E. A. D. M., & Chadi, G. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802480291 · Cited by 2
Personalized therapy in multiple sclerosis: state of art and future perspectives
D’Amico, E., Zanghì, A., & Patti, F. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1199950 · Cited by 2
Meta-analysis of optical coherence tomography in multiple sclerosis
Petzold, A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649506.010 · Cited by 2
Self-citation
Biomarkers of Disease Progression
Petzold, A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_7 · Cited by 2
Self-citation
Clinical review of retinotopy
Bijvank, J. N., Wenniger, L. J. M. D. B., de Graaf, P., & Petzold, A. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-320563 · Cited by 2
Self-citation
Therapeutic Targeting of Histone Deacetylation to Prevent Alzheimer's Disease.
Chacko, S., & Ladiges, W. (2021) · PubMed · Cited by 2
Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review)
Popov, K., Alekseeva, T. M., Назаров, В. Д., Vlasenko, A. I., & Малышев, С. М. (2023) · Neuromuscular Diseases · doi:10.17650/2222-8721-2023-13-3-33-39 · Cited by 2
Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis
Groen, K., Lechner‐Scott, J., Pohl, D., Levy, M., Giovannoni, G., & Hawkes, C. H. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102931 · Cited by 2
Biomarkers in Huntington’s Disease
Killoran, A. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_10 · Cited by 3
Association between serum neurofilament light chains and Life’s Essential 8: A cross-sectional analysis
Wang, T., Yan, L., Ma, T.-C., & Gao, X.-R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0306315 · Cited by 1
EPHA5 and SOD2 genetic variants and their link to neurofilament light chain: early detection of taxane-induced neurotoxicity in Egyptian breast cancer patients
Kassem, A. B., Ahmed, A. A., El‑Bassiouny, N. A., Omran, G. A., Kamel, M. M., Bastawisy, A. E., & Abuelsoud, N. N. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00827-1 · Cited by 1
A Programmable, 3D Neuron‐On‐Chip Platform Integrating Near Real‐Time Biosensing and Multiaxial Loading for Mechanobiological Injury Profiling
Khetani, S., Yong, K. W., Alhasadi, M. F., Hamedzadeh, A., Shahsavari, L., Rafiei, A., Wu, K., Agbojo, O., Singh, A., Karan, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202510309 · Cited by 1
Plasma neurofilament light chain as a predictor of multiple system atrophy in idiopathic REM sleep behavior disorder
Jin, B., Kim, S., Lee, S., Ha, S. H., Woo, K. A., Shin, J. H., Jung, K., & Kim, H. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13559-2 · Cited by 1
REM Sleep Behavior Disorder: Pathophysiology, Biomarkers, and Therapeutic Strategies
Zhang, H., Zhang, S., Che, H., Wan, Y., Gao, H., & Yao, D. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin45114 · Cited by 1
Neural Stem Cell-Derived Exosomes-Transmitted miR-31-5p Promote Functional Recovery of Spinal Cord Injury by Shifting Astrocytes A1/A2 Polarization
Jiang, D., Yin, Z., Wu, X., Wang, X., Liang, B., Wei, X., & Yan, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05827-7 · Cited by 1
Comparison of TDP-43, NfL, and GFAP in cerebrospinal fluid and serum in Alzheimer’s disease
Manco, C., Righi, D., Sangiorgio, A. R., Pucci, B., Stefano, N. D., & Plantone, D. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02253-7 · Cited by 1
Buyang Huanwu Decoction promotes neurorepair after spinal cord injury through a Lactobacillus johnsonii–indole-3-lactic acid–AhR–PI3K/Akt axis
Dong, J., Cao, Y., Chen, X., Xie, T., Zhang, X., Zhao, Q., Shi, C., Miao, Q., Xu, Z., Yan, L., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01408-x · Cited by 1
Effects of physical exercise on neurofilament light chain in multiple sclerosis and other neurological disorders: A systematic review
León-Muñoz, A. D., Rubio‐Arias, J. Á., Ávila-Gandía, V., & Andreu‐Caravaca, L. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107357 · Cited by 1
Use of blood-based neurofilament light chain as an endpoint in clinical trials of neurodegenerative conditions: a scoping review
Zheng, Y., Bhalala, O. G., Chin, K. S., Watson, R., & Yassi, N. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14007-5 · Cited by 1
Beyond neurodegeneration: Systemic confounders of blood neurofilament light chain in aging and their implications for neurological biomarker interpretation
Bonvini, G., Sattin, D., Iraci, N., Dobrowolny, G., Cola, M. C. D., Musarò, A., Lunetta, C., & Zulueta, A. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112233 · Cited by 1
The relevance of buffer system ionic strength in immunoassay development
Petzold, A. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.11.013 · Cited by 1
Self-citation
Diagnostic Approach to ICU-acquired Weakness: Present and Future
Wieske, L., Schultz, M. J., & Horn, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-35109-9_64 · Cited by 1
All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light-Chain Levels in US General Adults
Cai, Y., Wei, Q., Wang, S., & Lu, X. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae102 · Cited by 1
Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus.
Ahmadzade, A., Simani, L., Roozbeh, M., Farsad, F., Sheibani, M., Negaresh, O., Emam, M. M., Rajaei, A., Kazempour, M., Ramezani, M., et al. (2024) · PubMed Central · doi:10.22088/cjim.15.1.6 · Cited by 1
Neurofilaments in traumatic brain injury - current knowledge
Fialová, L. (2018) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2018.013 · Cited by 1
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Biomarker for Traumatic Brain Injury and Neurointensive Care : Its Scientific Efficacy and Prospects
Yokobori, S., Yamaguchi, M., Fujiki, Y., Igarashi, Y., Hashizume, A., Inoue, Y., Onda, H., Fuse, A., & Yokota, H. (2014) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.23.973 · Cited by 1
Investigation of biomarker variations post-return of spontaneous circulation following an out-of-hospital cardiac arrest
Golea, A. C., Rusu, A., Dumulesc, C., & Bala, C. G. (2017) · Revista română de medicină de laborator · doi:10.1515/rrlm-2017-0012 · Cited by 1
Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
Huţanu, A., Maier, S., Bălașa, R., Oprea, O. R., Barbu, Ș., Voidăzan, S. T., & Dobreanu, M. (2018) · Revista română de medicină de laborator · doi:10.2478/rrlm-2018-0004 · Cited by 1
SERUM PHOSPHORYLATED NEUROFILAMENT HEAVY CHAIN AS A MARKER OF AXONAL INJURY AND DISEASE SEVERITY IN MULTIPLE SCLEROSIS PATIENTS
Elsattar, D. A., AbdElghaffar, A., Aidaros, M., Ebeary, M. E., & Shawky, N. (2020) · Medicine Updates · doi:10.21608/muj.2020.29230.1010 · Cited by 1

Authors: Petzold, A.
Affiliations: UCL Queen Square Institute of Neurology (GB)
Corresponding author: Petzold, Axel
ORCID: Petzold, Axel
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 2005-06
Volume: 233
Issue: 1-2
Pages: 183-198
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/j.jns.2005.03.015
OpenAlex: W2133652987
Cited by: 688
References: 135
Citations by year: 2026: 26 · 2025: 44 · 2024: 40 · 2023: 49 · 2022: 46 · 2021: 65 · 2020: 42 · 2019: 54 · 2018: 38 · 2017: 27 · 2016: 24 · 2015: 23 · 2014: 38 · 2013: 27 · 2012: 24
FWCI: 1.17
Type: journal article
Language: en
Open access: green
discovery.ucl.ac.uk
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords: neurofilaments, axonal injury, axonal degeneration, surrogate markers, neurofilament assembly, multiple sclerosis, demyelinating disease, neurodegeneration
MeSH terms: Animals, Axons, Enzyme-Linked Immunosorbent Assay, Glycosylation, Humans, Immunohistochemistry, Models, Biological, Nerve Degeneration, Phosphorylation, Blotting, Western, Biomarkers, Neurofilament Proteins, Protein Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks